Avecia and TriLink to Integrate Technology | GenomeWeb

This article has been updated from a previous version to include additional information about the partnership.

NEW YORK, Feb. 27 (GenomeWeb News) - Avecia and TriLink announced today they will adopt common technology to offer customers "seamless" scale-up in oligo development and manufacturing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.